PLoS One-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-05-21 ms5000001355002405

2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗

0 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-10-11 1e18c142m55(暂无匿称)

投稿命中率:95.0
经验分享：呵呵

112 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-09-26 ms1000001829678046

收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。

126 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-10-18 若素9442

偏重的研究方向：肿瘤
经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊

153 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-10-25 ms7000002055690251

偏重的研究方向：肿瘤
经验分享：咨询各位同仁！
10月12投稿，
10月17稿件返回，要求提交伦理原件，
10月18重新提交，
今天10月25还是manuscript submitted to journal状态
已经两周了，还没送审，我要继续等吗

167 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-11-13 presson

10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催

144 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2021-12-14 1259e63fm64暂无昵称

Decision in Process一般要持续多久？

167 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-12-09 乐观的526 来自河北省

under review后需要多久？

148 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-12-05 ms1000000206078055 来自江苏省

请问网药加动物实验验证可收吗

146 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221453, encodeId=2144122145342, content=2021年12月初投稿，2022年5月21日稿件状态还是“editor invited”，还要等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c61f6411594, createdName=ms5000001355002405, createdTime=Sat May 21 21:14:22 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0 经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090405, encodeId=56cf209040582, content=收到编辑回来的回信，说是修改。里面有一栏审稿人对作者的评价，包括了1234条，第五条就是审稿人具体的建议。我需要对前面1234条的问题进行回复吗？求大神解答。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24af5537779, createdName=ms1000001829678046, createdTime=Mon Sep 26 08:43:24 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094366, encodeId=c1fd209436633, content=偏重的研究方向：肿瘤 经验分享：刚投出去，已经半个月了，还是Manuscript Submitted to Journal，着急明年毕业，还来得及吗，要不要催稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIBIaVXAjmGbWDnIwUczEXEaeRiasW0G2JL6GgskzOwsfR6ttH6ef4da1VeA6MHtyT9y1LCMMm2lCA/132, createdBy=2bb25254374, createdName=若素9442, createdTime=Tue Oct 18 09:43:09 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096015, encodeId=39332096015d2, content=偏重的研究方向：肿瘤 经验分享：咨询各位同仁！ 10月12投稿， 10月17稿件返回，要求提交伦理原件， 10月18重新提交， 今天10月25还是manuscript submitted to journal状态 已经两周了，还没送审，我要继续等吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Tue Oct 25 12:07:46 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100250, encodeId=62642100250df, content=10.5号投稿，现在还在with editor ，这个杂志有点慢呀，也不知道要不要催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Sun Nov 13 14:08:53 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079805, encodeId=ecd110e9805ac, content=Decision in Process一般要持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9a22579141, createdName=1259e63fm64暂无昵称, createdTime=Tue Dec 14 08:15:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105089, encodeId=09622105089e5, content=under review后需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Fri Dec 09 15:51:32 CST 2022, time=2022-12-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2104491, encodeId=ade321044918a, content=请问网药加动物实验验证可收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4a5728572, createdName=ms1000000206078055, createdTime=Mon Dec 05 22:28:32 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099592, encodeId=29a42099592f5, content=纯数据库做的临床预测模型好发吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 11:35:53 CST 2022, time=2022-11-10, status=1, ipAttribution=)]

2022-11-10 14699180m53暂无昵称

纯数据库做的临床预测模型好发吗？

183 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务